Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

UPMC studies feasibility of gene therapy for osteoporosis

March 25, 1998

Novel treatment for red blood cell disorders available for licensing

March 25, 1998

NIH will license out new technology for studying bone metabolism

March 25, 1998

ST-630 successfully completes phase Ia trial for osteoporosis

March 25, 1998

Pyridorin looks promising for diabetic complications in preclinical models

March 23, 1998

Inhibitors of CETP for hyperlipidemia/atherosclerosis in development at Bayer

March 23, 1998

First regulatory filing for Vasomax in MED

March 23, 1998

MK-677 shows efficacy in reversing diet-induced nitrogen wasting

March 23, 1998

Patient enrollment completed for phase III studies of pramlintide

March 20, 1998

Fluoxetine for premature ejaculation

March 20, 1998

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...